BACK TO MAIN BIOCONCENTRATION (PARTITION COEFFICIENT) TEST SUBSTANCE Identity: Perfluorooctanesulfonate; may also be referred to as PFOS or FC-95. (1-Octanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8heptadecafluoro-, potassium salt, CAS # 2795-39-3) Remarks: The test substance is a white powder.

BACK TO MAIN SELECTED FLUOROCHEMICALS IN THE DECATUR, ALABAMA AREA Prepared for: 3M St.

BACK BIODEGRADATION TEST SUBSTANCE Identity: Remarks: Perfluorooctanoic acid, ammonium salt; may also be referred to as PFOA, PFOA ammonium salt, Ammonium perfluorooctanoate, FC-116, FC-126, FC-169, or FC-143.

Manufacturer ofHigh Performance TCI PTFEComposites andLaminates TCI MATERIALS FOR FOOD APPLICATIONS FDA AND EUROPEAN COMPLIANCE TCLs a manufacturer of a high-performance materials used in the food processing industry.

4 A, --44i5WL kiiiV- iO- N\NY N'Air" ..1tIV\P14/1\JkAk RESEARCH TOXICOLOGY CENTRE ROMA 7850 MUTATION IN L5178Y TKO"'' MOUSE LYMPHOMA CELLS (FLUCTUATION METHOD) FINAL REPORT RTC Study no.: 52410 Sponsor: SOLVAY SOLEXIS S.p.A.

Apr 25, 2023 Comment on Proposed Restriction of PFAS Conference of Fluoro-Chemical Product Japan (FCJ) On behalf of chemical manufacturers, we, Conference of Fluoro-Chemical Product Japan (FCJ), have been working tirelessly to comply with national chemical regulations.

# ?

We attach non-confidential information for Specific Information Re Please see the following sheets.

General Comments for Annex XV restriction report on Per- and polyfluoroalkyl substances (PFAS) 22 May 2023 We welcome the opportunity to contribute to the public consultation initiated by the European Chemicals Agency regarding potential restriction of Per- and polyfluoroalkyl substances (PFAS) according to Regulation (EC) No. 1907/2006 ("REACH").

Apr 25, 2023 Comment on Proposed Restriction of PFAS Conference of Fluoro-Chemical Product Japan (FCJ) On behalf of chemical manufacturers, we, Conference of Fluoro-Chemical Product Japan (FCJ), have been working tirelessly to comply with national chemical regulations.

Annex III - Honeywell ACLAR packaging cost estimates and analysis In this document, Honeywell reviews the testing requirements and on this basis calculates cost estimates to requalify and repackage drugs packed using Aclar barrier films.

1 =I=EJ sPsaren in AR2Z6.

/,i'qorthwest Bioanaiytical Study No.

. : SE atheros &.Bvt,PD.

Genotoxicity, Carcinogenicity, Developmental Effects and Reproductive Effects of Perfluorooctanoate: A Perspective from Available Animal and Human Studies Prepared for the Association of Plastics Manufacturers of Europe and the Society of the Plastics Industry John L.